dr. o’reilly on the potential role of veliparib in pancreatic cancer
Published 4 years ago • 133 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:59
dr. o’reilly on the utility of parp inhibitors in pancreatic cancer
-
1:32
dr. o’reilly on the role of germline testing in pancreatic cancer
-
1:58
dr. o'reilly on areas of research in pancreatic cancer
-
1:51
dr. o’reilly on investigational treatment approaches in pancreatic cancer
-
1:18
dr. o’reilly on ongoing trials with parp inhibitors in pancreatic cancer
-
2:56
eileen o'reilly, md, on the phase 2 study comparing chemo with or without veliparib in pancreas
-
2:24
dr. o'reilly on tarextumab combinations for metastatic pancreatic cancer
-
2:14
dr. o’reilly on agents in development in advanced pancreatic cancer
-
2:04
dr. eileen m. o'reilly on factors to consider in pancreatic cancer treatment
-
1:09
dr. o'reilly on immunotherapy in pancreatic cancer
-
5:00
the potential for immunotherapy in pancreatic cancer
-
1:53
dr. o'reilly on resistance to immunotherapy in pancreatic cancer
-
1:20
dr. o'reilly discusses biomarker research in pancreatic cancer
-
1:07
quality of life data for parp inhibitor shows promise for pancreatic cancer treatment
-
12:23
emerging therapies for pancreatic cancer
-
1:53
dr. ulahannan on the prodige 35 trial in pancreatic cancer
-
1:56
eileen m. o'reilly, md: the significance of second-line therapy in pancreatic cancer
-
1:18
dr. o'reilly discusses advancements in early stage pancreatic cancer
-
1:13
dr. o'reilly discusses new developments in pancreatic cancer care